| P2093 | author name string | G Rothe | |
| | G Schmitz | |
| | A S Herr | |
| P2860 | cites work | Alterations in phenotype and cell‐surface antigen expression levels of human monocytes: Differential response to in vivo administration of rhm‐csf or rhgm‐csf | Q71811611 |
| | Pathogenesis of atherosclerosisand the role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors | Q71857110 |
| | Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia | Q71930679 |
| | Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages | Q72073826 |
| | The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages | Q72094692 |
| | Requirement for mevalonate in acetylated LDL induction of cholesterol esterification in macrophages | Q72325369 |
| | Antiatherosclerotic activity of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase in cholesterol-fed rabbits: a biochemical and morphological evaluation | Q72495022 |
| | Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation | Q72562906 |
| | Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima. Role of cell-mediated immunity in human atherogenesis | Q72731014 |
| | Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers | Q73284461 |
| | HMG-CoA reductase inhibitors suppress macrophage growth induced by oxidized low density lipoprotein | Q73589906 |
| | Enhanced upregulation of the Fc gamma receptor IIIa (CD16a) during in vitro differentiation of ApoE4/4 monocytes | Q77318978 |
| | Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease | Q22248076 |
| | Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain | Q24309556 |
| | Functional rafts in cell membranes | Q27860768 |
| | Polymorphism of apolipoprotein E. III. Effect of a single polymorphic gene locus on plasma lipid levels in man | Q28291625 |
| | Apolipoprotein E: cholesterol transport protein with expanding role in cell biology | Q28294791 |
| | Posttranslational modification of proteins by isoprenoids in mammalian cells | Q28303329 |
| | Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells | Q28509783 |
| | Cross-linking of Fc gamma receptor I (Fc gamma RI) and receptor II (Fc gamma RII) on monocytic cells activates a signal transduction pathway common to both Fc receptors that involves the stimulation of p72 Syk protein tyrosine kinase | Q28633899 |
| | Regulation of the mevalonate pathway | Q29547763 |
| | The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 |
| | Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease | Q29614952 |
| | CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein | Q29615189 |
| | 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma | Q29615221 |
| | An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma) | Q29615693 |
| | Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 |
| | Signal transduction by lymphocyte antigen receptors | Q29619894 |
| | PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines | Q29620217 |
| | The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation | Q29620219 |
| | Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E | Q33962949 |
| | Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis | Q34171790 |
| | Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein | Q34244809 |
| | Dendritic cells: from ontogenetic orphans to myelomonocytic descendants. | Q41266906 |
| | Transcriptional activation by amphipathic carboxylic peroxisomal proliferators is induced by the free acid rather than the acyl-CoA derivative | Q41475184 |
| | Detergent insolubility of alkaline phosphatase during biosynthetic transport and endocytosis. Role of cholesterol. | Q41573320 |
| | Stimulation of tyrosine phosphorylation and calcium mobilization by Fc gamma receptor cross-linking. Regulation by the phosphotyrosine phosphatase CD45. | Q41578406 |
| | Cell-mediated immunity in atherosclerosis. | Q41614969 |
| | Transcriptional and post-transcriptional control of apolipoprotein E gene expression in differentiating human monocytes | Q41643620 |
| | A transferrin-like GPI-linked iron-binding protein in detergent-insoluble noncaveolar microdomains at the apical surface of fetal intestinal epithelial cells | Q41815942 |
| | Effect of lovastatin on intimal hyperplasia after balloon angioplasty: A study in an atherosclerotic hypercholesterolemic rabbit | Q43470332 |
| | Simvastatin but not pravastatin inhibits the proliferation of rat aorta myocytes | Q43521139 |
| | T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1 | Q43879904 |
| | Polyclonal origin of T lymphocytes in human atherosclerotic plaques | Q44143784 |
| | Immunohistochemical and ultrastructural demonstration of the lymphocyte-macrophage interaction in human aortic intima | Q44609418 |
| | Effect of pravastatin on outcomes after cardiac transplantation. | Q46203599 |
| | Effect of lovastatin on suppression and regression of atherosclerosis in lipid-fed rabbits | Q46640864 |
| | CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factor | Q49299158 |
| | Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. | Q51012002 |
| | Both sphingolipids and cholesterol participate in the detergent insolubility of alkaline phosphatase, a glycosylphosphatidylinositol-anchored protein, in mammalian membranes. | Q54177549 |
| | Vastatins Inhibit Tissue Factor in Cultured Human Macrophages | Q57398943 |
| | Functionally abnormal monocytes in hypercholesterolemia | Q57398964 |
| | A more mature phenotype of blood mononuclear phagocytes is induced by fluvastatin treatment in hypercholesterolemic patients with coronary heart disease | Q62661495 |
| | Altered mononuclear phagocyte differentiation associated with genetic defects of the lysosomal acid lipase | Q62661510 |
| | Enhancement of the antigen-presenting function of monocytes by cholesterol: possible relevance to inflammatory mechanisms in extrinsic allergic alveolitis and atherosclerosis | Q67531506 |
| | Membrane molecules which trigger the production of interleukin-1 and tumor necrosis factor-alpha by lipopolysaccharide-stimulated human monocytes | Q67537110 |
| | Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis | Q67902011 |
| | Evidence for an altered lipid metabolic state in circulating blood monocytes under conditions of hyperlipemia in swine and its implications in arterial lipid metabolism | Q68068812 |
| | An immunohistochemical analysis of human aortic fatty streaks | Q68943921 |
| | Human monocyte activation induced by an anti-CD14 monoclonal antibody | Q69061120 |
| | Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response | Q69742103 |
| | HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits | Q70644784 |
| | Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis | Q70863401 |
| | Morphological fate and sequelae of human atherosclerosis: evaluation of immune mechanisms in atherogenesis through immunohistological and ultrastructural analysis | Q70950217 |
| | Accessory signaling by CD40 for T cell activation: induction of Th1 and Th2 cytokines and synergy with interleukin-12 for interferon-gamma production | Q71425955 |
| | Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients | Q71662347 |
| | Expression of the macrophage scavenger receptor in atheroma. Relationship to immune activation and the T-cell cytokine interferon-gamma | Q71799262 |
| | The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients | Q34306860 |
| | Protein lipidation in cell signaling | Q34308460 |
| | T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein | Q34390132 |
| | Identification and characterization of a novel monocyte subpopulation in human peripheral blood. | Q34418064 |
| | Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis | Q34541589 |
| | Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression | Q34734065 |
| | Biochemistry of protein prenylation | Q35654997 |
| | Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation | Q35753356 |
| | Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis | Q35764383 |
| | Inhibition of atherosclerosis in CD4 T-cell-ablated and nude (nu/nu) C57BL/6 hyperlipidemic mice | Q35782654 |
| | Enhanced monocyte progenitor cell proliferation in bone marrow of hyperlipemic swine | Q35816937 |
| | Detection of activated T lymphocytes in the human atherosclerotic plaque | Q35817589 |
| | Expression of intercellular adhesion molecule-1 in atherosclerotic plaques | Q35830615 |
| | The prenylation of proteins | Q35911259 |
| | Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis | Q36028683 |
| | T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse | Q36142970 |
| | Differential extractability of influenza virus hemagglutinin during intracellular transport in polarized epithelial cells and nonpolar fibroblasts | Q36219903 |
| | Correctly sorted molecules of a GPI-anchored protein are clustered and immobile when they arrive at the apical surface of MDCK cells | Q36232301 |
| | Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells | Q36232566 |
| | Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform | Q36235271 |
| | On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety | Q36365606 |
| | Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques. | Q37132394 |
| | IFN-gamma potentiates atherosclerosis in ApoE knock-out mice | Q37368296 |
| | The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice | Q37372718 |
| | Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization | Q37594710 |
| | Chlamydia pneumoniae, strain TWAR and atherosclerosis. | Q37889932 |
| | Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction. | Q37889936 |
| | Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain | Q37890285 |
| | Prenyl proteins in eukaryotic cells: a new type of membrane anchor | Q37923158 |
| | Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation | Q37926154 |
| | Expression patterns of Fc gamma receptors, HLA-DR and selected adhesion molecules on monocytes from normal and HIV-infected individuals. | Q39186726 |
| | Is atherosclerosis an immunologically mediated disease? | Q40606541 |
| | Branch-point reactions in the biosynthesis of cholesterol, dolichol, ubiquinone and prenylated proteins | Q40760033 |
| | Mechanisms of monocyte recruitment and accumulation | Q40872792 |
| | Cell dysfunction in atherosclerosis and the ischemic manifestations of coronary artery disease | Q40900648 |
| | Apolipoprotein E and the apolipoprotein E-deficient mouse | Q40926150 |
| | White blood cell count and cardiovascular disease. Insights from the Framingham Study | Q41121224 |
| | Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR. | Q41131349 |
| | A central role of CD40 ligand in the regulation of CD4+ T-cell responses | Q41149910 |
| | The role of heat shock proteins in protection and pathophysiology of the arterial wall | Q41181626 |
| | Modification of macrophage function and effects on atherosclerosis. | Q41235077 |
| | To stick or not to stick: the new leukocyte homing paradigm | Q41238906 |
| P433 | issue | 3 | |
| P304 | page(s) | 168-177 | |
| P577 | publication date | 1998-05-01 | |
| P1433 | published in | Herz | Q2143725 |
| P1476 | title | T-lymphocytes and monocytes in atherogenesis | |
| P478 | volume | 23 | |